Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model.

Liu Q. et al, (2022), BMC Med, 20

Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study

Dounavi ME. et al, (2022), Journal of Neurology

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

KOYCHEV I. et al, (2021), Brain Communications

Secondary prevention of dementia: Combining risk factors and scalable screening technology

KOYCHEV I. and Ojakäär T., (2021), Frontiers in Neurology

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Sen A. et al, (2021), Trials, 22

Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.

Rogers JP. et al, (2021), J Neurol Neurosurg Psychiatry

Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.

Muurling M. et al, (2021), Alzheimers Res Ther, 13

Brexpiprazole versus placebo or other antidepressive agents for treating depression

Ralovska S. et al, (2021), Cochrane Database of Systematic Reviews, 2021

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Raman B. et al, (2021), EClinicalMedicine

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.

Raman B. et al, (2021), EClinicalMedicine, 31

Evaluation of [13N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.

Egerton A. et al, (2020), EJNMMI Res, 10

Dementias Platform UK Clinical Studies and Great Minds Register: protocol of a targeted brain health studies recontact database.

Koychev I. et al, (2020), BMJ Open, 10

Prediction of Alzheimer's disease biomarker status defined by the 'ATN framework' among cognitively healthy individuals: results from the EPAD longitudinal cohort study.

Calvin CM. et al, (2020), Alzheimers Res Ther, 12

Blood-based ATN biomarkers of Alzheimer’s disease: A meta-analysis

KOYCHEV I. et al, (2020), Journal of Alzheimer's Disease

Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.

Koychev I. et al, (2020), J Nucl Med, 61, 1413 - 1418

Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study.

Vaci N. et al, (2020), Br J Psychiatry, 1 - 7

Evaluating the Feasibility of Frequent Cognitive Assessment Using the Mezurio Smartphone App: Observational and Interview Study in Adults With Elevated Dementia Risk (Preprint)

Lancaster C. et al, (2020), JMIR Mhealth Uhealth

Real-World Effectiveness, Its Predictors and Onset of Action of Cholinesterase Inhibitors and Memantine in Dementia: A Retrospective Health Record Study of 7400 Individuals using the UK CRIS Platform

KOYCHEV I. et al, (2020), British Journal of Psychiatry

The Dementias Platform UK (DPUK) Data Portal.

Bauermeister S. et al, (2020), Eur J Epidemiol, 35, 601 - 611

Gallery Game: Smartphone-based assessment of long-term memory in adults at risk of Alzheimer's disease.

Lancaster C. et al, (2020), J Clin Exp Neuropsychol, 42, 329 - 343

Load More

Include forthcoming?